Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

BP-lowering effects of SGLT-2 inhibitors and finerenone: an indirect comparison in patients with chronic kidney disease and type 2 diabetes.

  • Authors : Georgianos PI; 2nd Department of Nephrology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Kourtidou C

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Feb; Vol. 25 (2), pp. 127-130. Date of Electronic Publication: 2024 Feb 26.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Recent advances in the treatment of patients with obesity and chronic kidney disease.

  • Authors : Abdul Wahab R; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.; Cohen RV

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Annals of medicine [Ann Med] 2023 Dec; Vol. 55 (1), pp. 2203517.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Cardiorenal benefits of finerenone: protecting kidney and heart.

  • Authors : González-Juanatey JR; Cardiology Department, Hospital Clínico Universitario Santiago de Compostela, Centro de investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Santiago de Compostela, Spain.; Górriz JL

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/complications

  • Source: Annals of medicine [Ann Med] 2023 Dec; Vol. 55 (1), pp. 502-513.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print Cited Medium:

Record details

×
Editorial & Opinion

Advice and challenges in the pharmacotherapeutic management of diabetic kidney disease in adults.

  • Authors : Plattner C; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.; Pirklbauer M

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2023 Sep-Dec; Vol. 24 (16), pp. 1747-1752. Date of Electronic Publication: 2023 Aug 21.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study.

  • Authors : Cheng Y; Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.; Liu Y

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/complications ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (1), pp. 2295425. Date of Electronic Publication: 2024 Jan 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease.

  • Authors : Lerma E; Section of Nephrology, University of Illinois at Chicago/Advocate Christ Medical Center, Oak Lawn, IL, USA.; White WB

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy

  • Source: Postgraduate medicine [Postgrad Med] 2023 Apr; Vol. 135 (3), pp. 224-233. Date of Electronic Publication: 2022 Apr 20.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0401147 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Incidence and Risk Factors Associated with Outpatient Hypoglycemia in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Study.

  • Authors : Kaewput W; Department of Military and Community Medicine, Phramongkutklao College of Medicine , Bangkok, Thailand.; Thongprayoon C

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*epidemiology ; Hospitalization/Hospitalization/Hospitalization/*statistics & numerical data

  • Source: Endocrine research [Endocr Res] 2020 Nov; Vol. 45 (4), pp. 217-225. Date of Electronic Publication: 2020 Jul 14.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8408548 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*etiology ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*etiology

  • Source: Current medical research and opinion [Curr Med Res Opin] 2020 Feb; Vol. 36 (2), pp. 219-227. Date of Electronic Publication: 2019 Nov 06.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease.

  • Authors : Shelke V; Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani, India.; Kale A

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/genetics

  • Source: Archives of physiology and biochemistry [Arch Physiol Biochem] 2024 Apr; Vol. 130 (2), pp. 230-241. Date of Electronic Publication: 2022 Jan 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9510153 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.

  • Authors : Tong L; a Division of Nephrology and Hypertension , Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center , Torrance , CA , USA.; Adler S

Subjects: Primary Health Care*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*metabolism

  • Source: Postgraduate medicine [Postgrad Med] 2018 May; Vol. 130 (4), pp. 381-393. Date of Electronic Publication: 2018 Apr 18.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0401147 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  214 results for ""Diabetic Nephropathies""